CN103091490A - Quantitative ELISA (Enzyme Linked Immunosorbent Assay) detection method for antigen 146S of foot and mouth disease A as well as kit and application thereof - Google Patents
Quantitative ELISA (Enzyme Linked Immunosorbent Assay) detection method for antigen 146S of foot and mouth disease A as well as kit and application thereof Download PDFInfo
- Publication number
- CN103091490A CN103091490A CN2013100172094A CN201310017209A CN103091490A CN 103091490 A CN103091490 A CN 103091490A CN 2013100172094 A CN2013100172094 A CN 2013100172094A CN 201310017209 A CN201310017209 A CN 201310017209A CN 103091490 A CN103091490 A CN 103091490A
- Authority
- CN
- China
- Prior art keywords
- antigen
- type
- aftosa
- elisa
- detection method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 116
- 102000036639 antigens Human genes 0.000 title claims abstract description 116
- 108091007433 antigens Proteins 0.000 title claims abstract description 116
- 238000001514 detection method Methods 0.000 title claims abstract description 52
- 238000002965 ELISA Methods 0.000 title claims abstract description 47
- 241000710198 Foot-and-mouth disease virus Species 0.000 title claims abstract description 34
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 38
- 238000012360 testing method Methods 0.000 claims abstract description 21
- 238000003118 sandwich ELISA Methods 0.000 claims abstract description 12
- 230000035945 sensitivity Effects 0.000 claims abstract description 9
- 229960005486 vaccine Drugs 0.000 claims description 43
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 claims description 27
- 241000700199 Cavia porcellus Species 0.000 claims description 16
- 230000000890 antigenic effect Effects 0.000 claims description 15
- 238000011534 incubation Methods 0.000 claims description 12
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 11
- 229930006000 Sucrose Natural products 0.000 claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 10
- 238000013016 damping Methods 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 9
- 210000002966 serum Anatomy 0.000 claims description 9
- 239000005720 sucrose Substances 0.000 claims description 9
- 238000010790 dilution Methods 0.000 claims description 8
- 239000012895 dilution Substances 0.000 claims description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 7
- 238000006467 substitution reaction Methods 0.000 claims description 7
- 239000000758 substrate Substances 0.000 claims description 7
- 102000003992 Peroxidases Human genes 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 238000003205 genotyping method Methods 0.000 claims description 6
- 238000012417 linear regression Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000013207 serial dilution Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 101710145634 Antigen 1 Proteins 0.000 claims description 5
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 claims description 4
- 238000002835 absorbance Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 229920000136 polysorbate Polymers 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 238000013441 quality evaluation Methods 0.000 claims description 3
- 239000012925 reference material Substances 0.000 claims description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 description 19
- 229960004793 sucrose Drugs 0.000 description 9
- 238000010171 animal model Methods 0.000 description 7
- 241000700605 Viruses Species 0.000 description 6
- 238000000432 density-gradient centrifugation Methods 0.000 description 6
- 230000036039 immunity Effects 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000001542 size-exclusion chromatography Methods 0.000 description 3
- 102100031673 Corneodesmosin Human genes 0.000 description 2
- 101710139375 Corneodesmosin Proteins 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 241001493546 Suina Species 0.000 description 1
- 230000010530 Virus Neutralization Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940028617 conventional vaccine Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 210000000003 hoof Anatomy 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001303 quality assessment method Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 206010048282 zoonosis Diseases 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
本发明公开了一种A型口蹄疫146S抗原定量ELISA检测方法，包括以下步骤：1）储备A型口蹄疫标准对照抗原；2）纯化定量A型口蹄疫标准对照抗原146S；3）建立A型口蹄疫间接夹心ELISA方法；4）绘制标准对照抗原标准曲线；5）计算被检样品146S抗原含量；6）检测敏感性和特异性。并提供了应用此检测方法的试剂盒。本发明的有益效果为：本发明提供的一种A型口蹄疫146S抗原定量ELISA检测方法在测定口蹄疫抗原的含量时，既能计算出抗原含量，又能对抗原进行分型，以其原理制备的试剂盒，敏感、特异、操作简单、省时省力、稳定性好、适合于批量检测，且能区分血清型。The invention discloses a quantitative ELISA detection method for type A foot-and-mouth disease 146S antigen, which comprises the following steps: 1) storing type A foot-and-mouth disease standard control antigen; 2) purifying and quantifying type A foot-and-mouth disease standard control antigen 146S; 3) establishing type A foot-and-mouth disease indirect sandwich ELISA method; 4) Drawing standard control antigen standard curve; 5) Calculating the content of 146S antigen in the tested sample; 6) Detection sensitivity and specificity. And a kit for applying the detection method is provided. The beneficial effect of the present invention is: a kind of A-type foot-and-mouth disease 146S antigen quantitative ELISA detection method provided by the present invention can not only calculate the antigen content, but also carry out typing to the antigen when measuring the content of the foot-and-mouth disease antigen. The kit is sensitive, specific, easy to operate, saves time and effort, has good stability, is suitable for batch testing, and can distinguish serotypes.
Description
Technical field
The present invention relates to a kind of A type aftosa 146S antigen quantify ELISA detection method and kit and application.
Background technology
Aftosa (foot and mouth disease, FMD) is a kind of acute, hot, the height contagious disease that the Some Livestock such as pig, ox, sheep and other artiodactyl suffer from altogether, and susceptible animal reaches kind more than 70.Clinical symptoms is in mucous membrane of mouth, hoof and skin of breast generation blister rash.This disease route of transmission is many, speed is fast, and once outbreak of epidemic worldwide repeatedly, caused huge politics, economic loss.OIE (OIE) classifies it as must notifiable infectious disease, and China also classifies it as first of a class zoonosis.
Foot and mouth disease virus (foot and mouth disease virus, FMDV) belongs to micro ribonucleic acid Viraceae Hostis, seven serotypes is arranged: O type, A type, Asia I type, C type and South Africa 1,2,3 types.There is no cross protection between each serotype.Present stage China's Major Epidemic O type, A type and Asia I type.
Vaccine inoculation is one of effective means of prevention, control aftosa.In China, inactivated foot-and-mouth disease vaccine uses the most extensive; Safe and effective for guaranteeing it, its quality is carried out strict control very necessary.At present, general vaccine potency detection method is this animal protest test in the world, or adopts PD
50Determination method (Europe): namely use vaccine 50% animal protection dosage (PD
50) estimate immune effect of vaccine, conventional vaccine need reach 3 PD at least
50, urgent vaccine inoculation need reach 6 PD at least
50Or adopt (PGP) determination method (South America): namely protect percent (PGP) to estimate immune effect of vaccine with vaccine, PGP reaches more than 75%, and this vaccine is qualified, and PGP is 62.5%～68.8%, need to carry out duplicate test, and PGP is less than 62%, and this vaccine is defective.The animal of this animal protest test must be from without aftosa area, without this animal of non-vaccine immunity of foot and mouth disease virus neutralizing antibody.Control the popular of aftosa and break out because China takes the compulsory immunization means, so shaker test animal difficult; In addition, the cost of this method is high, the cycle long, repeatability is relatively poor, and needs high safe animal house, and is not easy to operate.
For this reason, the researcher has carried out the research of the multiple method of inspection, attempts substituting this animal protest test.These researchs mainly are divided three classes: serology method of substitution, experimental animal method of substitution and vaccine antigen sizing technique.
It is to estimate vaccine immunity effect by the antibody titer level after the detection vaccine immunity that aftosa serum is learned effect detection alternative method, mainly comprises the test of virus neutralization tests and LPB-ELISA.Nineteen sixty-eight, Stellman etc. have proposed to analyze with NAT the statistical method of vaccine potency; By 1976, Pay etc. set up the correlation formula of antigen dose, NAT and the protection ratio of vaccine according to the relation of NAT and vaccine potency.Ma Junwu etc. have detected vaccine immunity antibody by LPB-ELISA and have attacked poison protection Analysis deterrmination the aftosa immune antiboidies such as ox, sheep, pig and attacked the malicious relation of protecting.The vaccine immunity serum antibody titer detects and must can't fundamentally replace the use of this animal with non-aftosa vaccine immune animal, and the selection of animal still has difficulties.
The experimental animal method of substitution is to replace this animal with experimental animal (as mouse, cavy etc.), carries out the vaccine potency check.Research is found, carries out the potency test of ox inactivated foot-and-mouth disease vaccine with cavy, with the PD of this animal efficacy test
50Between correlativity is arranged preferably (Eissner etc. 1976; Terpstra etc. 1976), also available mouse or BALB/c mouse substitute the ox Indirect evaluation effect of inactivated foot-and-mouth disease vaccine (Sutmoller etc. 1980; DusSantos etc. 2000).Substituting experimental animal is fit to breeding scale, and homogeneity is easily controlled, and experimental animal and this animal are attacked the PD after poison
50Be certain positive correlation, but substituting experimental animal with immune response this animal, certain difference arranged, and what use during substituting experimental animal artificial challenge virus is the test strain, distinct on strain and route of infection with natural infection.
Foot and mouth disease virus is when sucrose density gradient centrifugation, and is different according to sedimentation coefficient, can be divided into complete virus particle (146S or 140S), hollow capsid (76S), virus infections related peptide (45S), 12 S protein subunits (12S).Research finds, complete virus particle (146S or 140S) is the principal ingredient that in inactivated foot-and-mouth disease vaccine, the induced animal body produces protective immune response, so in vaccine, the immune protection effectiveness of complete virus particle content and vaccine has obvious correlativity.The quantitative the whole bag of tricks of FMD vaccine antigen is is also researched and developed accordingly, mainly comprises sucrose density gradient centrifugation, sandwich ELISA method and size exclusion chromatography method.
1971, Fayet etc. set up the method that quantitatively detects aftosa complete virus particle in saccharose gradient (146S or 140S) with ultraviolet light; Subsequently, Barteling and Meloen(1974) and Doel etc. further perfect to it, and in nineteen eighty-two to the OIE formal recommendation.In three more than ten years after this, the method is widely used by aftosa vaccine researcher and the supplier of countries in the world as the classical way of aftosa vaccine antigen quantify always.But this method also has its shortcoming: complicated operation, instrument are expensive, repeatability is relatively poor, be not suitable for a large amount of sample detection, can't distinguish serotype.
By comparison, the sandwich ELISA method that (1995) such as Van Maanen etc. (nineteen ninety) and Crowther are set up has more advantage: simple to operate, time saving and energy saving, good stability, be suitable for batch detection, and can distinguish serotype (bivalent seedling and multivalence seedling are particularly important detecting).They with for the neutralizing monoclonal antibody of VP1 linear epitope as capture antibody with detect antibody, set up the double antibodies sandwich ELISA that can detect 146S antigen, and the impact that not existed by 12 S protein subunits.But such monoclonal antibody is not easy to be separated to, and has limited its widespread use.
Size exclusion chromatography (SEC) is called again gel filtration chromatography, or molecular sieve chromatography, is a kind of liquid chromatography isolation technics.Be mainly used in the separation of macromolecular substances such as protein.This technology also is used to the separation of FMD virion, quantitative (Spitteler etc., 2011), first foot-and-mouth disease antigen is separated with molecular sieve, then uses determination of ultra-violet (254nm), calculates the content of aftosa complete virus particle (140S).It is reported, the testing result of this method and the accordance of sucrose density gradient centrifugation are fine, operate also simple than the latter; But it is the same with the latter, can not distinguish serotype.
The exploration of this animal of inactivated foot-and-mouth disease vaccine efficacy test alternative method is a problem that faces both at home and abroad and need to be resolved hurrily, and effectively alternative method should have good specificity, susceptibility and repeatability, and will be easy to standardization.
Summary of the invention
Purpose of the present invention is exactly for above-mentioned defective of the prior art, and a kind of advantage that had both kept sucrose density gradient centrifugation is provided, and has again the A type aftosa 146S antigen quantify ELISA detection method of the speciality of ELISA method.
To achieve these goals, technical scheme provided by the invention is: a kind of A type aftosa 146S antigen quantify ELISA detection method comprises the following steps:
1) deposit A type aftosa standard control antigen;
2) the quantitative A type of purifying aftosa standard control antigen 1 46S;
3) set up the indirect sandwich ELISA method of A type aftosa;
4) drawing standard contrast antigen typical curve;
5) calculate test sample 146S antigenic content;
6) detection sensitivity and specificity.
Further, above-mentioned a kind of A type aftosa 146S antigen quantify ELISA detection method in described step 1), is to A type aftosa standard control antigen, and a part is put-70 ℃ of deposits (only thaw once, be used for the ELISA test) by 5 mL/bottles; Another part is put-70 ℃ of deposits (only thaw once, be used for the 146S antigen purification and quantitatively (divide three times)) by 3 * 100 mL.
Further, above-mentioned a kind of A type aftosa 146S antigen quantify ELISA detection method, described step 2) in, be to utilize sucrose density gradient method (45%, 35%, 25%, 15%), A type aftosa standard control antigen is carried out purifying, and measuring the 146S antigenic content is 2.42 μ g/ml.
Further, above-mentioned a kind of A type aftosa 146S antigen quantify ELISA detection method, in described step 3), the process of setting up the indirect sandwich ELISA method of A type aftosa is specific as follows:
A) coated elisa plate: be about to 1 μ l aftosa A type rabbit anti-serum with coated damping fluid (pH 9.6) the dilution aftosa A type rabbit anti-serum of carbonate (the Lanzhou veterinary institute provides) to working concentration (1:1000) and add in the coated damping fluid of 1000 μ l carbonate), mixing, every hole adds 50 μ l in the bottom, shakes after 2-3 minute with shrouding film shrouding or puts ambient temperature overnight in wet box;
B) washing elisa plate: take the shrouding film off, discard liquid in elisa plate, every hole fill it up with cleansing solution (0.01M pH 7.4 phosphate tween damping fluids, 1 * PBST), discard liquid after standing 30 seconds, repeat 4 times, pat dry;
C) application of sample: will contrast antigen and tested antigen from 1:2 with 1 * PBST, namely 50 μ l antigens add 50 μ l PBST, begin to do 2 times of serial dilutions to 1:256, and every hole adds 50 μ l, and 37 ℃, incubation 1 hour with PBST washing elisa plate 4 times, pats dry;
D) adding two resists: use guinea pig antiserum diluted aftosa A type guinea pig antiserum to working concentration (1:1000, being about to 1 μ l aftosa A type guinea pig antiserum adds in 1000 μ l guinea pig antiserum dilutions), the guinea pig antiserum dilution is for containing 10% normal cow's serum, the PBST of 5% Healthy Rabbits serum, every hole adds 50 μ l, shrouding, 37 ℃, incubation washed elisa plate 4 times with PBST after 1 hour, patted dry;
E) enzyme-added: as to dilute the anti-cavy of rabbit-horseradish peroxidase bond to working concentration (1:500 with 1 * PBST, being about to the 1 anti-cavy of μ l rabbit-horseradish peroxidase bond adds in 1000 μ l PBST), every hole adds 50 μ l, 37 ℃ of incubations washed elisa plate 4 times with PBST after 1 hour, patted dry;
F) colour developing: every hole adds 50 μ l substrate solutions, 37 ℃ of incubations 15 minutes, and described substrate solution is 20mmol/L o-phenylenediamine OPD, 0.05M citric acid phosphoric acid salt buffer, 0.015%H
2O
2
G) stop: every hole adds 50 μ l stop buffer cessation reactions again, and described stop bath is that concentration is 1.25% H
2SO
4
H) measure: read absorbance value under the 490nm wavelength.
Further, above-mentioned a kind of A type aftosa 146S antigen quantify ELISA detection method, in described step 4), be concentration take standard control antigen as horizontal ordinate, the OD value is ordinate, the drawing standard curve.
Further, above-mentioned a kind of A type aftosa 146S antigen quantify ELISA detection method in described step 5), is to find corresponding concentration with the OD value of sample by typical curve, then multiply by extension rate, obtains the actual concentrations of sample;
Or the linear regression equation that calculates typical curve with concentration and the OD value of reference material, the OD value substitution equation with sample calculates sample concentration, then multiply by extension rate, obtains the actual concentrations of sample.
Further, above-mentioned a kind of A type aftosa 146S antigen quantify ELISA detection method, in described step 6), that A type aftosa 146S antigen is made serial dilution, the minimum antigenic content of the linear regression equation that calculates typical curve with concentration and the OD value of standard control antigen, during as tested antigen, detection reaction OD value is less than the sensitivity Detection value of standard control antigen with foot-and-mouth disease antigen to be measured.
Second purpose of the present invention has been to provide a kind of A type aftosa 146S antigen quantify ELISA detection kit, and described A type aftosa 146S antigen quantify ELISA detection kit is to detect with above-mentioned A type aftosa 146S antigen quantify ELISA detection method.
The 3rd purpose of the present invention has been to provide a kind of A type aftosa 146S antigen quantify ELISA detection kit at A type foot-and-mouth disease antigen quantitatively and the application in antigens genotyping.
The 4th purpose of the present invention has been to provide the application of a kind of A type aftosa 146S antigen quantify ELISA detection kit in aftosa quality evaluation and antigens genotyping.
A type aftosa 146S antigen quantify ELISA kit, ultimate principle is first with sucrose density gradient centrifugation, A type foot-and-mouth disease antigen to be carried out quantitatively (parallel 3 times), take it as standard control antigen, other sample is carried out ELISA to be detected, first with the coated microwell plate of aftosa A type rabbit anteserum, make insolubilized antibody, add successively antigen samples, aftosa A type guinea pig serum, the anti-cavy IgG of horseradish peroxidase mark, form coated antibody-antigen-second antibody-hrp-antibody complex, add again the substrate solution colour developing, acid adding stops, the depth of color and the A type aftosa 146S antigen concentration in sample are proportionate.Measure absorbance (OD value) with microplate reader, by the concentration of A type foot-and-mouth disease antigen in the typical curve calculation sample under the 490nm wavelength.
Beneficial effect of the present invention is: a kind of A type aftosa 146S antigen quantify ELISA detection method provided by the invention had both kept the advantage (internationally recognized) of sucrose density gradient centrifugation, the speciality that has again the ELISA method, the indirect sandwich ELISA method of the antigen quantify that the present invention sets up, emphasis have solved A type foot-and-mouth disease antigen quantitatively and vaccine potency check substitution problem; The present invention is when measuring the content of foot-and-mouth disease antigen, can calculate antigenic content, can carry out somatotype to antigen again, with the kit of its principle preparation, responsive, special, simple to operate, time saving and energy saving, good stability, be suitable for batch detection, and can distinguish serotype, both can be used for half-finished on-line monitoring in the production of A type aftosa vaccine, can optimize production of vaccine technique again, also can be used as the external inspection technology of aftosa finished product vaccine, the quality of assessment vaccine, the potency test of alternative this animal.The present invention will produce the aspects such as on-line monitoring, vaccine process optimization, vaccine quality assessment, vaccine potency check and play a significant role at antigen.
The experiment effect explanation:
1, A type aftosa 146S antigen quantify ELISA detection method is at A type foot-and-mouth disease antigen quantitatively and the application in antigens genotyping:
With the indirect sandwich ELISA method of A type aftosa, 5 parts of A type foot and mouth disease virus 146s antigenic contents are measured three times, result is stable, good reproducibility, detect simultaneously the antigen (O type and Asia I type) of 2 parts of other types, result shows that all lower than its sensitivity range the specificity of this invention is good.As shown in table 1 is that indirect ELISA is to 5 parts of A type foot-and-mouth disease virus antigens and 2 parts of other type antigen 1 46s antigenic content measurement results.
2, the application of A type aftosa 146S antigen quantify ELISA detection method in aftosa quality evaluation and antigens genotyping:
With the indirect sandwich ELISA method of A type aftosa, 3 parts of A type inactivated foot-and-mouth disease vaccine 146s antigenic contents are measured three times, result is stable, good reproducibility; Other type inactivated foot-and-mouth disease vaccine (O type and A type, each 2 parts) 146s antigenic content is measured, and result shows that all lower than its sensitivity range the specificity of this invention is good.As shown in table 2 is that indirect ELISA is to 3 parts of A type inactivated foot-and-mouth disease vaccines and 4 parts of other type antigen 1 46s antigenic content measurement results.
Annotate: the finished product vaccine is first used emulsion breaker (normal butyl alcohol) breakdown of emulsion, and centrifugal (4 ℃, 5000rpm 20min), the sucking-off antigen part, then detect with the ELISA method.
Description of drawings
Fig. 1 is the operating process schematic diagram of a kind of A type aftosa 146S antigen quantify ELISA detection method provided by the invention.
Embodiment
The source of present embodiment agents useful for same and material:
1, in this test, agents useful for same is provided by Lanzhou Veterinary Inst., Chinese Acedemy of Agaricultural Sciences.
2, A type aftosa standard control antigen and tested antigen samples all have the middle peasant Witter effective company of biological share to provide.
3, Sigma company: the anti-IgG of the rabbit of horseradish peroxidase-labeled, OPD, carbonate buffer solution capsule, citric acid phosphoric acid salt tablets, PEG6000.
4, elisa plate is that costar company produces, and the antigen diluent plate is produced by Shenzhen Jin Can company.
5, experiment process as shown in Figure 1.
Embodiment 1:
A kind of A type aftosa 146S antigen quantify ELISA detection method comprises the following steps:
1) deposit A type aftosa standard control antigen:
To A type aftosa standard control antigen, a part is put-70 ℃ of deposits (only thaw once, be used for the ELISA test) by 5 mL/bottles; Another part is put-70 ℃ of deposits (only thaw once, be used for the 146S antigen purification and quantitatively (divide three times)) by 3 * 100 mL;
2) the quantitative A type of purifying aftosa standard control antigen 1 46S:
Utilize sucrose density gradient method (45%, 35%, 25%, 15%), A type aftosa standard control antigen is carried out purifying, measuring the 146S antigenic content is 1.74 μ g/ml;
3) set up the indirect sandwich ELISA method of A type aftosa:
Specific as follows:
A) coated elisa plate: be about to 1 μ l aftosa A type rabbit anti-serum with coated damping fluid (pH 9.6) the dilution aftosa A type rabbit anti-serum of carbonate (the Lanzhou veterinary institute provides) to working concentration (1:1000) and add in the coated damping fluid of 1000 μ l carbonate), mixing, every hole adds 50 μ l in the bottom, shakes after 2-3 minute with shrouding film shrouding or puts ambient temperature overnight in wet box;
B) washing elisa plate: take the shrouding film off, discard liquid in elisa plate, every hole fill it up with cleansing solution (0.01M pH 7.4 phosphate tween damping fluids, 1 * PBST), discard liquid after standing 30 seconds, repeat 4 times, pat dry;
C) application of sample: will contrast antigen and tested antigen from 1:2 with 1 * PBST, namely 50 μ l antigens add 50 μ l PBST, begin to do 2 times of serial dilutions to 1:256, and every hole adds 50 μ l, and 37 ℃, incubation 1 hour with PBST washing elisa plate 4 times, pats dry;
D) adding two resists: use guinea pig antiserum diluted aftosa A type guinea pig antiserum to working concentration (1:1000, being about to 1 μ l aftosa A type guinea pig antiserum adds in 1000 μ l guinea pig antiserum dilutions), the guinea pig antiserum dilution is for containing 10% normal cow's serum, the PBST of 5% Healthy Rabbits serum, every hole adds 50 μ l, shrouding, 37 ℃, incubation washed elisa plate 4 times with PBST after 1 hour, patted dry;
E) enzyme-added: as to dilute the anti-cavy of rabbit-horseradish peroxidase bond to working concentration (1:500 with 1 * PBST, being about to the 1 anti-cavy of μ l rabbit-horseradish peroxidase bond adds in 1000 μ l PBST), every hole adds 50 μ l, 37 ℃ of incubations washed elisa plate 4 times with PBST after 1 hour, patted dry;
F) colour developing: every hole adds 50 μ l substrate solutions, 37 ℃ of incubations 15 minutes, and described substrate solution is 20mmol/L o-phenylenediamine OPD, 0.05M citric acid phosphoric acid salt buffer, 0.015%H
2O
2
G) stop: every hole adds 50 μ l stop buffer cessation reactions again, and described stop bath is that concentration is 1.25% H
2SO
4
H) measure: read absorbance value under the 490nm wavelength;
4) drawing standard contrast antigen typical curve:
Take the concentration of standard control antigen as horizontal ordinate, the OD value is ordinate, the drawing standard curve;
5) calculate test sample 146S antigenic content:
Be to find corresponding concentration with the OD value of sample by typical curve, then multiply by extension rate, obtain the actual concentrations of sample;
Or the linear regression equation that calculates typical curve with concentration and the OD value of reference material, the OD value substitution equation with sample calculates sample concentration, then multiply by extension rate, obtains the actual concentrations of sample;
6) detection sensitivity and specificity:
That A type aftosa 146S antigen is made serial dilution, the minimum antigenic content of the linear regression equation that calculates typical curve with concentration and the OD value of standard control antigen, during as tested antigen, detection reaction OD value is less than the sensitivity Detection value of standard control antigen with foot-and-mouth disease antigen to be measured.
It should be noted that at last: the above only is the preferred embodiments of the present invention, be not limited to the present invention, although with reference to previous embodiment, the present invention is had been described in detail, for a person skilled in the art, it still can be modified to the technical scheme that aforementioned each embodiment puts down in writing, and perhaps part technical characterictic wherein is equal to replacement.Within the spirit and principles in the present invention all, any modification of doing, be equal to replacement, improvement etc., within all should being included in protection scope of the present invention.
Claims (10)
1. an A type aftosa 146S antigen quantify ELISA detection method, is characterized in that, comprises the following steps:
1) deposit A type aftosa standard control antigen;
2) the quantitative A type of purifying aftosa standard control antigen 1 46S;
3) set up the indirect sandwich ELISA method of A type aftosa;
4) drawing standard contrast antigen typical curve;
5) calculate test sample 146S antigenic content;
6) detection sensitivity and specificity.
2. a kind of A type aftosa 146S antigen quantify ELISA detection method according to claim 1, is characterized in that, in described step 1), to A type aftosa standard control antigen, a part is pressed the 5mL/ bottle, is placed in-70 ℃ of deposits, this part is only thawed once, is used for the ELISA test; Another part is placed in-70 ℃ of deposits by 3 * 100 mL, and this part is only thawed once, is used for the 146S antigen purification quantitative minutes for three times.
3. a kind of A type aftosa 146S antigen quantify ELISA detection method according to claim 2, it is characterized in that, described step 2) in, to utilize the sucrose density gradient method, gradient concentration is 45%, 35%, 25%, 15%, purifying A type aftosa standard control antigen, the mean value that records the 146S antigenic content for three times is 1.74 μ g/ml.
4. a kind of A type aftosa 146S antigen quantify ELISA detection method according to claim 3, is characterized in that, in described step 3), the process of setting up the indirect sandwich ELISA method of A type aftosa is specific as follows:
A) coated elisa plate: dilute aftosa A type rabbit anti-serum to working concentration with the coated damping fluid of the carbonate of pH 9.6, working concentration is 1:1000, being about to 1 μ l aftosa A type rabbit anti-serum adds in the coated damping fluid of 1000 μ l carbonate, mixing, every hole adds 50 μ l in the bottom, shakes after 2-3 minute with shrouding film shrouding or puts ambient temperature overnight in wet box;
B) washing elisa plate: take the shrouding film off, discard liquid in elisa plate, cleansing solution is filled it up with in every hole, and cleansing solution is 0.01M, the phosphate tween damping fluid of pH 7.4, and 1 * PBST discards liquid after standing 30 seconds, repeats 4 times, pats dry;
C) application of sample: will contrast antigen and tested antigen from 1:2 with 1 * PBST, namely 50 μ l antigens add 50 μ l PBST, begin to do 2 times of serial dilutions to 1:256, and every hole adds 50 μ l, and 37 ℃, incubation 1 hour with PBST washing elisa plate 4 times, pats dry;
D) adding two resists: use guinea pig antiserum diluted aftosa A type guinea pig antiserum to working concentration, working concentration is 1:1000, being about to 1 μ l aftosa A type guinea pig antiserum adds in 1000 μ l guinea pig antiserum dilutions, the guinea pig antiserum dilution is for containing 10% normal cow's serum, the PBST of 5% Healthy Rabbits serum, and every hole adds 50 μ l, shrouding, 37 ℃, incubation washed elisa plate 4 times with PBST after 1 hour, patted dry;
E) enzyme-added: as to dilute the anti-cavy of rabbit-horseradish peroxidase bond to working concentration with 1 * PBST, working concentration is 1:500, being about to the 1 anti-cavy of μ l rabbit-horseradish peroxidase bond adds in 1000 μ l PBST, every hole adds 50 μ l, 37 ℃ of incubations washed elisa plate 4 times with PBST after 1 hour, patted dry;
F) colour developing: every hole adds 50 μ l substrate solutions, 37 ℃ of incubations 15 minutes, and described substrate solution is 20mmol/L o-phenylenediamine OPD, 0.05M citric acid phosphoric acid salt buffer, 0.015%H
2O
2
G) stop: every hole adds 50 μ l stop buffer cessation reactions again, and described stop bath is that concentration is 1.25% H
2SO
4
H) measure: read absorbance value under the 490nm wavelength.
5. a kind of A type aftosa 146S antigen quantify ELISA detection method according to claim 4, is characterized in that, in described step 4), be concentration take standard control antigen as horizontal ordinate, the OD value is ordinate, the drawing standard curve.
6. a kind of A type aftosa 146S antigen quantify ELISA detection method according to claim 5, is characterized in that, in described step 5), is to find corresponding concentration with the OD value of sample by typical curve, then multiply by extension rate, obtains the actual concentrations of sample;
Or the linear regression equation that calculates typical curve with concentration and the OD value of reference material, the OD value substitution equation with sample calculates sample concentration, then multiply by extension rate, obtains the actual concentrations of sample.
7. a kind of A type aftosa 146S antigen quantify ELISA detection method according to claim 6, it is characterized in that, in described step 6), that A type aftosa 146S antigen is made serial dilution, the minimum antigenic content of the linear regression equation that calculates typical curve with concentration and the OD value of standard control antigen, during as tested antigen, detection reaction OD value is less than the sensitivity Detection value of standard control antigen with foot-and-mouth disease antigen to be measured.
8. A type aftosa 146S antigen quantify ELISA detection kit, it is characterized in that, described A type aftosa 146S antigen quantify ELISA detection kit detects with the arbitrary described A type aftosa 146S antigen quantify ELISA detection method of claim 1-7.
9. an A type aftosa 146S antigen quantify ELISA detection kit at A type foot-and-mouth disease antigen quantitatively and the application in antigens genotyping.
10. the application of an A type aftosa 146S antigen quantify ELISA detection kit in aftosa vaccine quality evaluation and antigens genotyping.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310017209.4A CN103091490B (en) | 2013-01-17 | 2013-01-17 | A kind of A type aftosa 146S antigen quantify ELISA detection method and kit thereof and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310017209.4A CN103091490B (en) | 2013-01-17 | 2013-01-17 | A kind of A type aftosa 146S antigen quantify ELISA detection method and kit thereof and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103091490A true CN103091490A (en) | 2013-05-08 |
| CN103091490B CN103091490B (en) | 2016-01-20 |
Family
ID=48204314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310017209.4A Active CN103091490B (en) | 2013-01-17 | 2013-01-17 | A kind of A type aftosa 146S antigen quantify ELISA detection method and kit thereof and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103091490B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104792990A (en) * | 2015-03-31 | 2015-07-22 | 洛阳莱普生信息科技有限公司 | A-type foot-and-mouth disease competition ELISA antibody detection kit |
| CN105467138A (en) * | 2015-12-04 | 2016-04-06 | 中国农业科学院兰州兽医研究所 | Method for determining components and estimating anti-gen content of foot-and-mouth disease vaccine |
| CN109613238A (en) * | 2018-12-20 | 2019-04-12 | 中牧实业股份有限公司 | Detect enzyme linked immunological kit and its application of foot-and-mouth disease a type Wuhan strain antigen |
| CN109765367A (en) * | 2019-01-31 | 2019-05-17 | 中国农业科学院兰州兽医研究所 | Visual rapid detection kit for type A foot-and-mouth disease virus and preparation method thereof |
| CN111239393A (en) * | 2020-03-06 | 2020-06-05 | 中国农业科学院兰州兽医研究所 | A method for detecting NSPs residues in foot-and-mouth disease inactivated antigen or inactivated vaccine |
| CN113189332A (en) * | 2021-04-19 | 2021-07-30 | 中国农业科学院兰州兽医研究所 | Foot-and-mouth disease virus liquid phase blocking BSA-ELISA antibody detection kit and application thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006138481A2 (en) * | 2005-06-15 | 2006-12-28 | The Trustees Of The University Of Pennsylvania | Detection of hiv-1 infection |
| CN1900115A (en) * | 2006-07-11 | 2007-01-24 | 中国农业科学院兰州兽医研究所 | Method for preparing monoclonal antibody resisting O-type foot and mouth disease virus and antibody and use |
| CN101082626A (en) * | 2007-06-14 | 2007-12-05 | 中国农业科学院兰州兽医研究所 | ELISA reagent kit for testing Asial type foot-and-mouth disease virus |
| CN101140281A (en) * | 2007-10-26 | 2008-03-12 | 云南省畜牧兽医科学研究所 | A Rapid Quantitative Method for Foot-and-Mouth Disease 146S Antigen |
| CN102517331A (en) * | 2011-12-26 | 2012-06-27 | 武汉中博生物股份有限公司 | 2 type subunit vaccine for porcine circovirus as well as preparation method and application thereof |
| CN102662062A (en) * | 2012-04-17 | 2012-09-12 | 中国农业科学院兰州兽医研究所 | Monoclonal antibody blocking enzyme-linked immunosorbent assay (ELISA) kit and method for detecting nonstructural protein (NSP) antibody of foot-and-mouth disease virus (FMDV) |
-
2013
- 2013-01-17 CN CN201310017209.4A patent/CN103091490B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006138481A2 (en) * | 2005-06-15 | 2006-12-28 | The Trustees Of The University Of Pennsylvania | Detection of hiv-1 infection |
| CN1900115A (en) * | 2006-07-11 | 2007-01-24 | 中国农业科学院兰州兽医研究所 | Method for preparing monoclonal antibody resisting O-type foot and mouth disease virus and antibody and use |
| CN101082626A (en) * | 2007-06-14 | 2007-12-05 | 中国农业科学院兰州兽医研究所 | ELISA reagent kit for testing Asial type foot-and-mouth disease virus |
| CN101140281A (en) * | 2007-10-26 | 2008-03-12 | 云南省畜牧兽医科学研究所 | A Rapid Quantitative Method for Foot-and-Mouth Disease 146S Antigen |
| CN102517331A (en) * | 2011-12-26 | 2012-06-27 | 武汉中博生物股份有限公司 | 2 type subunit vaccine for porcine circovirus as well as preparation method and application thereof |
| CN102662062A (en) * | 2012-04-17 | 2012-09-12 | 中国农业科学院兰州兽医研究所 | Monoclonal antibody blocking enzyme-linked immunosorbent assay (ELISA) kit and method for detecting nonstructural protein (NSP) antibody of foot-and-mouth disease virus (FMDV) |
Non-Patent Citations (2)
| Title |
|---|
| 李乐等: "ELISA用于口蹄疫病毒146S抗原快速定量的研究", 《中国预防兽医学报》, vol. 30, no. 4, 30 April 2008 (2008-04-30) * |
| 黄红亮等: "用抗O型口蹄疫病毒的单克隆抗体建立双抗夹心ELISA方法", 《猪的重要传染病防治研究新成果》, 31 December 2002 (2002-12-31) * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104792990A (en) * | 2015-03-31 | 2015-07-22 | 洛阳莱普生信息科技有限公司 | A-type foot-and-mouth disease competition ELISA antibody detection kit |
| CN105467138A (en) * | 2015-12-04 | 2016-04-06 | 中国农业科学院兰州兽医研究所 | Method for determining components and estimating anti-gen content of foot-and-mouth disease vaccine |
| CN105467138B (en) * | 2015-12-04 | 2018-01-26 | 中国农业科学院兰州兽医研究所 | A Method for Determining Components of Foot-and-Mouth Disease Vaccine and Estimating Antigen Content |
| CN109613238A (en) * | 2018-12-20 | 2019-04-12 | 中牧实业股份有限公司 | Detect enzyme linked immunological kit and its application of foot-and-mouth disease a type Wuhan strain antigen |
| CN109613238B (en) * | 2018-12-20 | 2021-02-09 | 中牧实业股份有限公司 | Enzyme linked immunosorbent assay kit for detecting foot-and-mouth disease A type Wuhan strain antigen and application thereof |
| CN109765367A (en) * | 2019-01-31 | 2019-05-17 | 中国农业科学院兰州兽医研究所 | Visual rapid detection kit for type A foot-and-mouth disease virus and preparation method thereof |
| CN111239393A (en) * | 2020-03-06 | 2020-06-05 | 中国农业科学院兰州兽医研究所 | A method for detecting NSPs residues in foot-and-mouth disease inactivated antigen or inactivated vaccine |
| CN113189332A (en) * | 2021-04-19 | 2021-07-30 | 中国农业科学院兰州兽医研究所 | Foot-and-mouth disease virus liquid phase blocking BSA-ELISA antibody detection kit and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103091490B (en) | 2016-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103076451B (en) | A kind of O type aftosa 146S antigen quantify ELISA detection kit and using method thereof | |
| CN103091490A (en) | Quantitative ELISA (Enzyme Linked Immunosorbent Assay) detection method for antigen 146S of foot and mouth disease A as well as kit and application thereof | |
| Rainwater-Lovett et al. | Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis | |
| CN102662062B (en) | Monoclonal antibody blocking enzyme-linked immunosorbent assay (ELISA) kit and method for detecting nonstructural protein (NSP) antibody of foot-and-mouth disease virus (FMDV) | |
| CN204882568U (en) | ELISA detect reagent box of pig O type foot and mouth disease virus antibody | |
| BRPI0709565A2 (en) | competitive enzyme-linked immunosorbent assay (c-elisa) for the detection of a specific flavivirus antibody | |
| Tekleghiorghis et al. | Comparison of test methodologies for foot-and-mouth disease virus serotype A vaccine matching | |
| CN103864906A (en) | Foot and mouth disease virus non-structural protein antibody enzyme-linked immunodetection kit | |
| Wang et al. | Understanding the epidemiological characteristics of EV71 and CVA16 infection to aid the diagnosis and treatment of hand, foot, and mouth disease | |
| CN103091270A (en) | Quantitative enzyme-linked immuno-sorbent assay (ELISA) detection method for Asia I-type foot-and-mouth disease antigens 146S as well as kit and application of quantitative ELISA detection method | |
| CN104569428B (en) | A kind of enterovirns type 71 killed vaccine antigen enzyme-linked immunologic detecting kit | |
| Yang et al. | Development of a competitive enzyme-linked immunosorbent assay for detection of antibodies against the 3B protein of foot-and-mouth disease virus | |
| Yang et al. | Generation of monoclonal antibodies against foot‐and‐mouth disease virus SAT 2 and the development of a lateral flow strip test for virus detection | |
| CN105675866A (en) | Solid-phase blocked ELISA (Enzyme Linked Immune Sorbent Assay) kit for detecting O-type FMDV (Foot and Mouth Disease Virus) antibody | |
| Cassaniti et al. | Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area | |
| Gnazzo et al. | Mouse model as an efficacy test for foot‐and‐mouth disease vaccines | |
| CN102854317A (en) | EV71 (human enterovirus 71) antigen enzyme-linked reaction detection kit and its preparation method | |
| Zhang et al. | Evaluation of the diagnostic performance and its associated factors of a commercial anti-EV-A71 IgM-capture ELISA kit in hospitalized children with clinical diagnostic HFMD | |
| Ackermann-Gäumann et al. | Vaccination against tick-borne encephalitis elicits a detectable NS1 IgG antibody response | |
| CN105348386B (en) | The monoclonal antibody cocktail and detection kit of the O-shaped virus of resistant to foot and mouth disease | |
| CN101241138A (en) | Asia 1 type foot-and-mouth disease antibody level detection test paper and preparation method | |
| Cerutti et al. | Large scale production and characterization of SARS‐CoV‐2 whole antigen for serological test development | |
| CN112881710B (en) | Inhibition ELISA method for detecting foot-and-mouth disease virus antibody and application thereof | |
| CN205333653U (en) | O type foot -and -mouth disease virus antibody detection card | |
| Xinglin et al. | Quantitative and qualitative study of enzyme-linked immunosorbent assay to detect IgG against Japanese encephalitis virus in swine sera |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |